Tag: ENB-003

ENB Therapeutics completes Phase 1 trial enrollment for ENB-003

ENB Therapeutics, a biotechnology firm working on therapeutics targeting the endothelin B receptor (ETBR), announced the completion of its international Phase 1 ENBOLDEN-101 trial enrollment. ... Read More